# Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity

> **NCT07304141** · — · COMPLETED · sponsor: **Göteborg University** · enrollment: 128 (actual)

## Conditions studied

- Obesity (Disorder)
- Child Obesity

## Interventions

- **OTHER:** Liraglutide 3 mg (Saxenda)

## Key facts

- **NCT ID:** NCT07304141
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-20
- **Primary completion:** 2025-12-12
- **Final completion:** 2025-12-12
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07304141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07304141, "Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07304141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*